The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Mucus Relief Congestion and Cough Maximum Strength
Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI · DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 400 mg/20mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/20mL · Liquid · Oral · TARGET Corporation
NDC 11673-0337-06 · 177 mL in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Cardinal Health (Leader) 70000 | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/10mL; GUAIFENESIN 200 mg/10mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| TARGET Corporation | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 400 mg/20mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Mucus Relief Congestion and Cough Maximum Strength — NDC 11673-0337-06," retrieved September 3, 2026, https://drugdashboards.com/drug/11673033706.
Free to cite with attribution — see how the data is put together.